Mammalian Copper Transporter 1 (CTR1) is a high affinity Cu influx transporter that also mediates uptake of platinum-containing chemotherapeutic agents including cisplatin (cDDP). Methionines 150, 154 and histidine 139 have been proposed to form a series of stacked rings in the pore formed by the CTR1 homotrimer, each of which is required for maximal Cu transport. To examine the mechanism by which hCTR1 also transports cDDP, variant forms of hCTR1 in which methionines 150 and 154 were converted to isoleucines, or in which histidine 139 was converted to alanine, were re-expressed in cells in which both alleles of CTR1 had been knocked out. Each of these conversions disabled Cu transport and increased cellular resistance to the cytotoxic effect of Cu. In contrast, conversion of the methionines increased the uptake and cytotoxicity of cDDP well above that attained with wild type hCTR1. Conversion of H139 to alanine did not impair cDDP uptake and actually enhanced cytotoxicity. Thus, while M150 and 154 facilitate the movement of Cu through the pore, they serve to obstruct the passage of cDDP.
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Cu is an essential trace metal required for multiple normal cell functions. It plays a key role in regulating metabolic pathways, controls the redox potential of the cell, serves as a cofactor with transcription factors such as p53, and may even be important in controlling cell trafficking (reviewed in (Madsen and Gitlin, 2007) ). The cellular level of Cu is maintained within a narrow range by a limited number of influx and efflux transporters. The influx transporters pass Cu to a series of intracellular chaperones that ensure that it is delivered to specific Cu-requiring enzymes in various compartments of the cell. The binding of Cu to chaperones also serves to protect the cell against the toxic effects of free Cu which is otherwise easily oxidized and capable of generating free radicals. Mutations that disable Cu efflux cause Menkes and Wilson's disease.
CTR1 is the major Cu influx transporter. Each monomer contains a 67 amino acid hydrophilic extracellular N-terminal domain, three transmembrane segments, and a short intracellular C-terminal tail. It assembles in the plasma membrane as a homotrimer where it forms a pore through which Cu is believed to pass (De Feo et al., 2009 ). The inner faces of the pore contain methionines, cysteines, and histidine residues that facilitate the movement of Cu into the cell down concentration gradient. Interactions between Cu and methionines 150 and 154, and histidine 139, are important determinants of the high affinity of CTR1 for Cu. These amino acids are thought to form a series of stacked rings each of which can chelate Cu +1 that is then handed down through the pore in a series of transchelation reactions (De Feo et al., 2009; Howell et al., 2010) . The requirement for sequential transchelation reactions appears to be the basis for the high selectivity of CTR1 which transports Cu +1 but not Cu +2 .
CTR1 is not just important for Cu transport but is also of interest because it regulates the cellular accumulation of the platinum-containing chemotherapeutic agents. Previous work from This article has not been copyedited and formatted. The final version may differ from this version. Larson et al., 2008) and other laboratories (Song et al., 2004) has shown that CTR1 mediates the uptake of cisplatin and is an important determinant of its cytotoxicity both in vitro and in vivo. Knockout of both alleles of CTR1 reduces initial cDDP influx , enhances efflux ) and renders cells highly resistant to cDDP. Reexpression of hCTR1 in cells lacking endogenous CTR1 restores cDDP uptake and sensitivity . Cu can trigger the down-regulation of CTR1, but in several types of cells cDDP does so at much lower concentrations and substantially more rapidly that Cu Jandial et al., 2009) . A key unanswered question is how the CTR1 homotrimer transports both the small Cu +1 ion and the much larger cDDP molecule.
As shown in Figure 1 , prior studies have established the importance of M150, M154 and H139 to the transport of Cu. These amino acids are of particular interest as structural studies suggest that they lie in the narrowest part of the pore formed by homotrimeric CTR1, and that methionines and histidines are often involved in binding Cu in other proteins. In order to examine the mechanism by which hCTR1 transports both Cu and cDDP, variant forms of hCTR1 in which both methionines were converted to isoleucines, or in which the histidine was converted to alanine, were re-expressed in cells in which both alleles of CTR1 had been knocked out.
Modification of M150 and 154, or of H139, disabled Cu transport and increased cellular resistance to the cytotoxic effect of Cu. However, these same modifications of M150 and 154 had the opposite effect on the transport of cDDP. cDDP accumulation was increased to an even greater extent than attained with wild type hCTR1 and this was accompanied by a further enhancement of cell kill. In contrast to the effect of converting H139 to alanine on Cu transport, there was little effect on cDDP uptake. None of these changes affected the ability of cDDP to trigger the degradation of hCTR. These results provide further evidence of the ability of hCTR1
This article has not been copyedited and formatted. The final version may differ from this version. Cell Survival Assay. The sulforhodamine B assay system (Monks et al., 1991) was used to determine cell survival following exposure to increasing concentrations of drug. Five thousand cells were seeded into the wells of a 96-well tissue culture plate. Cells were incubated overnight at 37°C, 5% CO 2 and then exposed to cDDP for 5 min, at 37°C, by the addition of 200 μ l Pt drug-containing DMEM-RS medium. After 5 min the drug-containing media was removed, cells were washed once with 37°C PBS, PBS was aspirated off and cells were covered in 200 μ l complete medium. Cells were allowed to grow for 5 days after which the media was removed, the plate was washed 3 times with PBS, the protein was precipitated with 50% trichloroacetic acid and stained using 100 μ l of 0.4% sulforhodamine B in 1% acetic acid at room temperature for 15 minutes. Following washing of the plate, the absorbance of each well at 515 nm was recorded using a Versamax Tunable Microplate Reader (Molecular Devices, Sunnyvale, CA).
All experiments were repeated no less than 3 times using 3 cultures for each drug concentration.
Immunocytochemistry. All images were visualized using a DeltaVision Deconvolution
Microscope System utilizing a Nikon TE-200 Microscope (Applied Precision, Inc., Issaquah, WA). Deconvolution and subsequent analysis was done using the softWoRx software suite (Applied Precision, Inc., Issaquah, WA)
Measurement of cellular drug accumulation. Drug accumulation was measured by
inductively-coupled plasma mass spectroscopy as described previously ); the only change made was the utilization of 1 ml of medium and DMEM-RS in place of OptiMEM.
This article has not been copyedited and formatted. The final version may differ from this version. qRT-PCR. myc-CTR1 mRNA was measured via qRT-PCR. First-strand cDNA was generated from Trizol-isolated mRNA (Invitrogen, Carlsbad, CA) using Oligo(dT) 20 priming and the SuperScript III First-Strand Kit (Invitrogen, Carlsbad, CA). qRT-PCR was performed using a Bio-Rad MyIQ qPCR machine (Hercules, CA). The forward and reverse primers for hCTR1, mCTR1 and GAPDH were, respectively: gatgatgatgcctatgacct, tcttgagtccttcatagaac, actgttgggcaacagatgct, ctgctgctactgcaatgcag, tcaccaccatggagaaggc, gctaagcagttggtggtgca.
Reactions utilized iQ SYBR Green Supermix (Bio-Rad, Hercules, CA), following the manufacturer's recommendations. Samples were prepared in quadruplicate with a minimum of 3 independent RNA isolates were used in independent experiments. Analysis was done using the Bio-Rad iQ5 system software (Hercules, CA). Figure 2A shows the relative levels of CTR1 mRNA expressed in the cell lines. The two variant forms of hCTR1 were expressed at 70% of the level of the wild type hCTR1. To further validate the system, the amount of hCTR1 in the plasma membrane was determined by exposing the cells to sulfo-NHS-SSbiotin which labels cell surface proteins. The proteins were recovered onto streptavadin beads and subjected to western blot analysis using antibodies that reacted with either the myc tag or α -subunit of Na abnormalities . As shown in Figure 3B , re-expression of the wild type hCTR1 resulted in a 2-fold increase in the rate of Cu accumulation when compared to uptake in the CTR1 -/-cells (p = 0.002). In contrast, neither of the hCTR1 variants was able to increase Cu uptake at all. Thus, the integrity of either or both of M150 and M154, and of H139, is essential for Cu transport to occur in this system.
To determine whether the differences in Cu accumulation translated into different tolerances to the cytotoxic effect of Cu, the growth rate of the CTR
, and CTR1 -/-/H139A cells was measured during a 96 h exposure to increasing concentrations of Cu. As shown in Figure 3C re-expression of the wild type CTR1 resulted in a 1.2-fold increase in sensitivity relative to the CTR1 -/-cells (IC 50 µM 37 ± 1 versus 46 ± 2 µM; p = 0.003). Neither of the CTR1 variants produced a biologically significant increase in sensitivity consistent with their failure to enhance Cu uptake.
CTR1 Regulation of cDDP Uptake and Cytotoxicity.
To analyze the effect of the M150,154I and the H139A substitutions on the initial influx of cDDP, the 4 types of cells were exposed to 30 µM cDDP for 5 min, washed thoroughly and the Pt content measured by ICP-MS.
As shown in Figure 4A , re-expression of wild type CTR1 resulted in a 4. relative to that in the CTR1 -/-/WT cells (p = 0.0002). The H139A variant also increased the initial influx of cDDP, in this case by a factor 3.5-fold over that in the CTR1 -/-cells (p = 0.009) which was 85% of the increase mediated by the wild type hCTR1. Thus, rather than impairing the transport of cDDP, converting M150 and M154 to a type of amino acid not known to chelate cDDP resulted in an increase rather than a decrease in cDDP influx.
To determine whether the changes in cDDP influx translated into changes in the cytotoxicity of this drug, cells were treated with increasing concentrations of cDDP for 5 min and their growth rate assessed over the ensuing 96 h. The re-expression of wild type CTR1 resulted in a 2.2-fold increase in cytotoxicity relative to the CTR1 -/-cells (IC 50 291 ± 7 versus 650 ± 40 µM; p = 0.002). Consistent with its ability to increase cDDP uptake to an even greater extent, the M150,154I variant increased the cytotoxicity of cDDP by a factor of 3.1-fold (p = 0.001) (IC 50 of 211 ± 7 µM) or 1.6-fold more than the wild type CTR1 (p = 0.001). Of interest, even though the H139A variant increased cDDP uptake somewhat less than the wild type hCTR1, it actually did a better job of enhancing cDDP cytotoxicity than the wild type hCTR1.
The IC 50 for the CTR1 -/-/H139A cells was 181 ± 3 µM reflecting a 3.6-fold increase in cytotoxicity relative to the CTR1 -/-cells (p=0.002), and a 1.6-fold increase over that produced by wild type CTR1 (p = 0.0005). Due to the discrepancy between the effect of the H139A variant on cDDP uptake versus cytotoxicity, this set of experiments was repeated a total of 5 times, all with consistent results. Thus, whereas the M150,154I and H139A variants were unable to transport Cu, they actually mediated enhanced uptake of cDDP.
Effect on cDDP-Induced Down-Regulation of CTR1. In mouse embryo fibroblasts cDDP triggers the rapid degradation of CTR1 via ubiquitination and subsequent degradation in the proteosome (Jandial et al., 2009) . To determine whether this reaction was a result of the This article has not been copyedited and formatted. The final version may differ from this version. , and CTR1 -/-/H139A cells was analyzed by immunocytochemistry. The top 3 panels of Figure 5 show that the distribution of hCTR1 was normal prior to cDDP exposure, and the lower 3 panels show that a 15 min exposure to 30 µM cDDP caused disappearance of nearly all the signal. Thus, M150, M154 or H139are not essential to the down-regulation of hCTR1 indicating that cDDP must be interacting with some other part of the molecule.
Discussion
Electron crystallographic analysis of CTR1 suggests that when the monomers assemble into a homotrimer in the plasma membrane, M150, M154 and H139 are positioned such that they can form 3 stacked rings in the pore (De Feo et al., 2009; De Feo et al., 2007) . These have been envision as mediating Cu +1 influx through a series of transchelation reactions in which Cu +1 is handed from one ring to the next down its concentration gradient. Based on the fact that the interaction of cDDP with methionines and histidines is very similar to that of Cu
+1
, we have proposed that hCTR1 transports cDDP in a similar manner (Howell et al., 2010) . However, the results reported here indicate that, although the transchelation concept may be correct, M150, M154 and H139 play quite different roles in the transport of Cu and cDDP.
The re-expression of wild type and variant forms of hCTR1 in cells in which endogenous CTR1 is completely absent due to knockout of both alleles provides a powerful way of identifying structural components essential for function. Despite small differences in the level of expression at the mRNA level, all 3 forms of hCTR1 protein assessed in this study were expressed at equal levels at the plasma membrane. In addition, the distribution of hCTR1 in other This article has not been copyedited and formatted. The final version may differ from this version. parts of the cell appeared normal indicating that M150, M154 and H139 are not important determinants of the normal trafficking of hCTR1. This model system was further validated by the observation that re-expression of wild type hCTR1 increased Cu and cDDP uptake and enhanced sensitivity to the cytotoxic effect of both of these drugs.
The fact that the M150,154I variant of hCTR1 failed to increase the uptake of Cu, and was unable to significantly enhance the cytotoxicity of Cu, is consistent with prior studies of Cu transport in yeast, insect and mammalian cells that established the importance of these methionines under conditions of low environmental Cu (Eisses and Kaplan, 2005; Liang et al., 2009; Puig et al., 2002) . Similarly, the observation that the H139A variant failed to transport Cu confirms the results of a prior study that reported that conversion of H139 to alanine reduced Cu uptake when the variant hCTR1 was expressed in insect cells (Eisses and Kaplan, 2005) . The most intriguing observation to emerge from this study is that, instead of disabling cDDP transport, conversion of M150 and M154 to isoleucines significantly increased cDDP uptake well above that attained with wild type hCTR1, and that this was accompanied by a further enhancement of the cytotoxicity of cDDP. This result indicates that the stacked rings of methionines putatively formed by M150 and M154 serve to obstruct the flow of cDDP through the pore. In the M150,154I variant the stacked rings potentially formed by H139 and C189 in the lower part of the pore remain intact and may continue to serve an essential transchelation role, but these data suggest that the interaction of cDDP with M150 and/or M154 in some way controls the rate of transport . A previous study performed in small cell lung cancer cells that contained endogenous hCTR1 found that expression of an exogenous form of hCTR1 in which either M150 or M154 were converted to glutamine reduced the uptake of cDDP and rendered the cells less sensitive to cDDP. However, this was attributed to a transdominant negative effect of This article has not been copyedited and formatted. The final version may differ from this version. Conversion of H139 to alanine did not significantly impair the ability of hCTR1 to mediate the uptake of cDDP, but it also did not enhance its uptake. This indicates that cDDP interaction with H139 is not essential to its transport and is consistent with the concept that the rings of methionines formed by M150 and M154 are more important determinants of flux. Of more interest is the fact that, while wild type hCTR1 and the H139A variant accumulated similar amounts of cDDP, the CTR1 -/-/H139A cells were substantially more sensitive to the cytotoxic effect of cDDP indicating that the potency of the accumulated drug was greater. The explanation for this is not readily apparent but may be related to alteration in the efficiency of transfer of cDDP to intracellular chaperones or a change in the ratio of cDDP that enters the cell via hCTR1
versus the other routes that must exist since CTR1 -/-cells still accumulate measurable amounts of cDDP. The idea that the H139A variant affects other possible transport routes is bolstered by its effect on basal Cu levels. Despite the fact that conversion of H139 to alanine disabled its ability to mediate Cu uptake, it nevertheless markedly reduced the basal intracellular Cu level in the CTR1 -/-cells.
In the mouse embryo fibroblasts cDDP triggers rapid degradation of endogenous CTR1, and the results of this study indicate that it does the same thing to exogenous hCTR1 when reexpressed in the CTR1 -/-cells. Previous studies have documented that CTR1 becomes ubiquitinated , and that inhibition of proteosome function blocks the cDDPinduced degradation of CTR1 and enhances the uptake and This article has not been copyedited and formatted. The final version may differ from this version. (Jandial et al., 2009) . The ability cDDP to trigger CTR1 degradation is compromised in cells that lack the Cu chaperone ATOX1 . How cDDP initiates CTR1 ubiquitination is unknown, but the results of this study support the conclusion that it does not require interaction of cDDP with M150, M54 or H139 indicating that cDDP must bind to some other domain in hCTR1 as well.
In summary, the opposite effects of converting M150 and M154 to isoleucines on the transport of Cu and cDDP indicate that, while they play a facilitating role in moving Cu through the pore, they serve to obstruct the passage of cDDP. Thus, although both Cu and cDDP may rely on a series of transchelation reactions to pass through the hCTR1 trimeric complex, the details of the molecular interactions must be different which provides a potential basis for selective pharmacologic modulation of Cu versus cDDP cytotoxicity. 
